BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16570049)

  • 21. History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates.
    Sonigo C; Seroka A; Cédrin-Durnerin I; Sermondade N; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1713-9. PubMed ID: 26960957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ABVD chemotherapy for Hodgkin lymphoma at a single institute].
    Ohshima R; Motomura S; Hashimoto C; Miyazaki T; Ito S; Takasaki H; Hyo R; Koharazawa H; Takemura S; Yamazaki E; Fujimaki K; Tomita N; Fujita H; Fujisawa S; Harano H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2010 Dec; 51(12):1756-61. PubMed ID: 21258185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
    Sibon D; Ertault M; Al Nawakil C; de Bazelaire C; Franchi P; Brière J; de Kerviler E; Beranger N; Thieblemont C; Brice P
    Br J Haematol; 2011 Apr; 153(2):191-8. PubMed ID: 21385169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.
    Suzuki T; Takeuchi M; Saeki H; Yamazaki S; Koga H; Abe D; Nishimura M; Nakaseko C; Nakasa H; Nakamura H; Ariyoshi N; Kitada M
    Clin Ther; 2010 Mar; 32(3):527-31. PubMed ID: 20399989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
    Younes A; Fayad L; Romaguera J; Pro B; Goy A; Wang M
    Eur J Cancer; 2006 Nov; 42(17):2976-81. PubMed ID: 17008093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective?
    Hamed RH; Anter AH; Awad IA
    Hematol Oncol Stem Cell Ther; 2012; 5(1):36-41. PubMed ID: 22446609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Present and future fertility preservation strategies for female cancer patients.
    Georgescu ES; Goldberg JM; du Plessis SS; Agarwal A
    Obstet Gynecol Surv; 2008 Nov; 63(11):725-32. PubMed ID: 18928577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience.
    Oktay K; Oktem O
    Fertil Steril; 2010 Feb; 93(3):762-8. PubMed ID: 19013568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors.
    Avivi I; Hardak E; Shaham B; Igla M; Rowe JM; Dann EJ
    Ann Hematol; 2012 Feb; 91(2):215-21. PubMed ID: 21603918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
    J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adolescent hodgkin lymphoma: are treatment results more favorable with pediatric than with adult regimens?
    Müller J; Illés A; Molnár Z; Rosta A; Váróczy L; Kovács G
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e60-3. PubMed ID: 21285900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
    Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
    Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
    N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
    Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
    Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
    Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
    J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy.
    Katsumata R; Sagawa R; Akechi T; Shinagawa Y; Nakaaki S; Inagaki A; Okuyama T; Akazawa T; Furukawa TA
    Jpn J Clin Oncol; 2010 Apr; 40(4):365-8. PubMed ID: 20026458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma.
    Radford JA; Lieberman BA; Brison DR; Smith AR; Critchlow JD; Russell SA; Watson AJ; Clayton JA; Harris M; Gosden RG; Shalet SM
    Lancet; 2001 Apr; 357(9263):1172-5. PubMed ID: 11323045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review and follow-up of patients using a regional sperm cryopreservation service: ensuring that resources are targeted to those patients most in need.
    Tomlinson M; Meadows J; Kohut T; Haoula Z; Naeem A; Pooley K; Deb S
    Andrology; 2015 Jul; 3(4):709-16. PubMed ID: 26084986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of fertility in patients treated for Hodgkin's lymphoma.
    Harel S; Fermé C; Poirot C
    Haematologica; 2011 Nov; 96(11):1692-9. PubMed ID: 21828120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.